Rev Esp Quimioter 2022;35(Suppl.3):25-29

Current treatment of nosocomial pneumonia and ventilator-associated pneumonia

ERIKA P. PLATA-MENCHACA, RICARD FERRER

Published: 24 October 2022

http://www.doi.org/10.37201/req/s03.06.2022

Hospital-acquired pneumonia and ventilator-associated pneumonia are severe nosocomial infections leading to high morbidity and mortality. Broad-spectrum antibiotics with coverage against all likely pathogens are recommended by the international guidelines. Inappropriate empirical treatment is one of the most important prognostic factors. Knowledge of local epidemiology and continuous microbiological surveillance is crucial for improving clinical approaches to empirical antimicrobial treatment. The development of protocols and policies for training healthcare professionals on preventive strategies, such as the “Pneumonia Zero” project, and improved implementation of antimicrobial stewardship practices, will aid early de-escalation of antibiotics and prevent resistance

Rev Esp Quimioter 2022; 35(Suppl.3):25-29 [Full-text PDF]